Black–white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US-Reference-Cited by-同舟云学术

Black–white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US

Published:2012-01-26 Issue:1 Volume:133 Page:285-296
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lipscomb Joseph,Gillespie Theresa W.,Goodman Michael,Richardson Lisa C.,Pollack Lori A.,Ryerson A. Blythe,Ward Kevin C.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-011-1916-1.pdf

Reference27 articles.

1. Bonadonna G, Valagussa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. NEJM 304:10–15

2. Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365:1687–1717

3. Clinical Practice Guidelines in Oncology (2011) Breast Cancer (version 3.2009) National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls?PDF/breast.pdf . Accessed 26 February 2011

4. National Cancer Institute, Physician Data Query. Breast Cancer Treatment. http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional . Accessed 17 June 2010

5. Muss HB, Berry DA, Cirrincione CT et al (2009) Adjuvant chemotherapy in older women with early-stage breast cancer. NEJM 360:2055–2065

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial disparities in initiation of chemotherapy among breast cancer patients with discretionary treatment indication in the state of Georgia;Breast Cancer Research and Treatment;2024-03-22

2. Racial and Ethnic Disparities in Cancer Occurrence and Outcomes in Rural United States: A Scoping Review;Cancer Control;2024-01

3. Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer;Breast Cancer Research and Treatment;2023-12-09

4. Race, ethnicity, and immune tolerance induction in hemophilia A in the United States;Research and Practice in Thrombosis and Haemostasis;2023-11

5. National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial;Breast Cancer Research and Treatment;2023-10-20